BioVaria is one of Europe’s leading events connecting technology scouts, business developers, and investors with commercially attractive licensing opportunities and promising life-science start-ups from across the continent.
This unique forum brings together top technology transfer professionals, innovators from academia, and emerging ventures with investors and representatives from the global biotech and pharmaceutical industry. The Startup Pitch & Partner Programme provides an exceptional platform for entrepreneurs to showcase their innovations, build strategic relationships, and accelerate their growth.
A platform for Europe’s life-science innovators
The interactive programme is designed for European life-science and biotechnology entrepreneurs, founders, and start-ups across all sectors, including biotech, medtech, and related fields. Participants will have the opportunity to present their business ideas, gain visibility among leading venture capitalists and industry partners, and connect directly with decision-makers actively seeking early-stage investment opportunities.
Organised in partnership between Ascenion and Max Planck Innovation, BioVaria builds on the strong legacy of the Biotech Networkshop and continues to support innovation emerging from Europe’s research and entrepreneurial ecosystem.
Why participate?
Apply
Submit your application via BioVaria.org to be considered for this exclusive programme, open to both early-stage and more established life-science ventures.
Pitch & Compete
Selected start-ups will present their innovation live on the BioVaria main stage to an expert jury and a highly qualified audience of investors and industry leaders. Up to 15 start-ups will be selected to compete for the prestigious BioVaria Startup Award, gaining valuable exposure and recognition.
Partner & Connect
Expand your network through dedicated partnering opportunities, including one-on-one speed dating sessions with investors and industry experts. BioVaria offers a unique environment to establish strategic partnerships and explore future collaboration and funding opportunities.



